Avidity Biosciences, Inc. Annual Operating Income (Loss) in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Avidity Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2023.
  • Avidity Biosciences, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$98.1M, a 67.4% decline year-over-year.
  • Avidity Biosciences, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$325M, a 46.2% decline year-over-year.
  • Avidity Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$236M, a 31.7% decline from 2022.
  • Avidity Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$179M, a 51.6% decline from 2021.
  • Avidity Biosciences, Inc. annual Operating Income (Loss) for 2021 was -$118M, a 167% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$236M -$56.7M -31.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 -$179M -$60.9M -51.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 -$118M -$73.8M -167% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 -$44.3M -$26.9M -155% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 -$17.3M -$6.83M -65.1% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 -$10.5M Jan 1, 2018 Dec 31, 2018 10-K 2021-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.